We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MYLAN-KING MERGER NOT A HIT WITH MAJOR SHAREHOLDERS
MYLAN-KING MERGER NOT A HIT WITH MAJOR SHAREHOLDERS
October 14, 2004
Generic heavyweight Mylan Laboratories’ pending acquisition of brand firm King Pharmaceuticals is drawing fire from Mylan’s two largest shareholders, as well as industry analysts.